- Home
- CVRX vs FRGE Comparison
CVRX vs FRGE Comparison
Compare CVRX & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- FRGE
- Stock Information
- Founded
- CVRX 2000
- FRGE 2014
- Country
- CVRX United States
- FRGE United States
- Employees
- CVRX N/A
- FRGE N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FRGE Computer Software: Prepackaged Software
- Sector
- CVRX Health Care
- FRGE Technology
- Exchange
- CVRX Nasdaq
- FRGE Nasdaq
- Market Cap
- CVRX 181.5M
- FRGE 175.1M
- IPO Year
- CVRX 2021
- FRGE N/A
- Fundamental
- Price
- CVRX $6.45
- FRGE $13.74
- Analyst Decision
- CVRX Buy
- FRGE Buy
- Analyst Count
- CVRX 7
- FRGE 5
- Target Price
- CVRX $14.50
- FRGE $38.25
- AVG Volume (30 Days)
- CVRX 516.1K
- FRGE 120.2K
- Earning Date
- CVRX 05-08-2025
- FRGE 05-07-2025
- Dividend Yield
- CVRX N/A
- FRGE N/A
- EPS Growth
- CVRX N/A
- FRGE N/A
- EPS
- CVRX N/A
- FRGE N/A
- Revenue
- CVRX $52,870,000.00
- FRGE $85,383,000.00
- Revenue This Year
- CVRX $13.92
- FRGE $21.15
- Revenue Next Year
- CVRX $19.89
- FRGE $28.65
- P/E Ratio
- CVRX N/A
- FRGE N/A
- Revenue Growth
- CVRX 25.62
- FRGE 16.04
- 52 Week Low
- CVRX $4.30
- FRGE $6.60
- 52 Week High
- CVRX $18.55
- FRGE $26.10
- Technical
- Relative Strength Index (RSI)
- CVRX 44.02
- FRGE 50.53
- Support Level
- CVRX $6.08
- FRGE $13.68
- Resistance Level
- CVRX $7.17
- FRGE $15.08
- Average True Range (ATR)
- CVRX 0.57
- FRGE 1.23
- MACD
- CVRX 0.14
- FRGE -0.23
- Stochastic Oscillator
- CVRX 65.03
- FRGE 8.32
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.